News

VolitionRX aims for cash flow neutrality in 2025 as human diagnostics licensing advances
Q1 2025 Management View Terig Hughes, Chief Financial Officer, reported a 35% year-on-year decline in total operating expenses, emphasizing cost reductions across all categories. Hughes highlighted: ...
Flexible Solutions International targets Q4 launch of new food-grade product, eyes $30M annual revenue potential by 2026 while advancing Panama plant
Q1 2025 Management View CEO Dan O'Brien began by emphasizing the company's focus on its NanoChem division (NCS), which ...